We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current 0RAA market cap is 52B. The company's latest EPS is EUR -5.9977 and P/E is -253.10.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 4.8M | 3.74M | 4.65M | 6.07M | 6.49M |
| Operating Income | -7.37M | -6.67M | -7.58M | -5.96M | -7.98M |
| Net Income | -7.97M | -8.31M | -6.71M | -6.97M | -205.44M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 5.64M | 14.35M | 14.88M | 16.52M | 77.93M |
| Total Liabilities | 9.92M | 14.11M | 14.48M | 17.8M | 280.28M |
| Total Equity | -4.28M | 237k | 398k | -1.28M | -202.35M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -3.84M | -5.99M | -6.26M | -5.47M | -1.14M |
| Investing | -448k | -2.99M | -2.96M | -858k | -56k |
| Financing | 1.25M | 11.3M | 7.68M | 5.71M | 1.68M |
| Market Cap | 52B |
| Price to Earnings Ratio | -253.10 |
| Price to Sales Ratio | 8.02k |
| Price to Cash Ratio | 66.58k |
| Price to Book Ratio | -256.96 |
| Dividend Yield | - |
| Shares Outstanding | 34.25M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 1,518.00 |
| 52 Week Low | 1,518.00 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Safe Orthopaedics Sa |
| Address |
80 rue de montepy, za de montepy fleurieux-sur-l'arbresle, auvergne-rhone-alpes 69210 |
| Website | https://safegrp.com/ |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
